Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2

BACKGROUND: After receiving a COVID-19 vaccine, most recipients want to know if they are protected from infection and for how long. Since neutralizing antibodies are a correlate of protection, we developed a lateral flow assay (LFA) that measures levels of neutralizing antibodies from a drop of bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lake, Douglas F., Roeder, Alexa J., Kaleta, Erin, Jasbi, Paniz, Pfeffer, Kirsten, Koelbela, Calvin, Periasamy, Sivakumar, Kuzmina, Natalia, Bukreyev, Alexander, Grys, Thomas E., Wu, Liang, Mills, John R, McAulay, Kathrine, Gonzalez-Moa, Maria, Seit-Nebi, Alim, Svarovsky, Sergei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567411/
https://www.ncbi.nlm.nih.gov/pubmed/34781240
http://dx.doi.org/10.1016/j.jcv.2021.105024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567411/
https://www.ncbi.nlm.nih.gov/pubmed/34781240
http://dx.doi.org/10.1016/j.jcv.2021.105024

Ejemplares similares